IGF1 and growth hormone-secreting pituitary adenoma: Regarding in vivo data, an interesting post-hoc analysis of the PAPE study described an increase in T2-weighted MRI signals in treated somatotroph adenomas; patients with these radiological findings exhibited a more pronounced decrease in IGF-1 irrespective of tumour shrinkage.